We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FIX icon
1126
Comfort Systems
FIX
$62.5B
$4.83M 0.01%
110,673
+17,962
+19% +$919K
EGHT icon
1127
8x8 Inc
EGHT
$318M
$4.83M 0.01%
267,780
+50,623
+23% +$931K
EIG icon
1128
Employers Holdings
EIG
$911M
$4.83M 0.01%
115,063
+16,378
+17% +$719K
OC icon
1129
Owens Corning
OC
$11.7B
$4.82M 0.01%
109,657
+1,816
+2% +$88K
AA icon
1130
Alcoa
AA
$12.4B
$4.81M 0.01%
180,811
+9,109
+5% +$306K
NXST icon
1131
Nexstar Media Group
NXST
$5.99B
$4.81M 0.01%
61,118
+19,887
+48% +$1.57M
RITM icon
1132
Rithm Capital
RITM
$5.72B
$4.8M 0.01%
338,163
+35,199
+12% +$595K
SUPN icon
1133
Supernus Pharmaceuticals
SUPN
$2.51B
$4.79M 0.01%
144,347
+25,153
+21% +$1.08M
BBBY
1134
DELISTED
Bed Bath & Beyond Inc
BBBY
$4.79M 0.01%
423,387
+168,063
+66% +$2.2M
SCL icon
1135
Stepan Co
SCL
$1.45B
$4.79M 0.01%
64,738
+10,241
+19% +$833K
HEI.A icon
1136
HEICO Corp Class A
HEI.A
$37.2B
$4.78M 0.01%
75,876
-3,646
-5% -$244K
LOPE icon
1137
Grand Canyon Education
LOPE
$3.93B
$4.77M 0.01%
49,647
-1,893
-4% -$220K
AXTA icon
1138
Axalta
AXTA
$8.05B
$4.75M 0.01%
202,984
-558
-0.3% -$13.9K
CTRE icon
1139
CareTrust REIT
CTRE
$9.65B
$4.75M 0.01%
257,049
+51,449
+25% +$958K
TPH
1140
DELISTED
Tri Pointe Homes
TPH
$4.72M 0.01%
432,199
+127,394
+42% +$1.51M
SEM
1141
DELISTED
Select Medical
SEM
$4.71M 0.01%
569,194
+102,752
+22% +$983K
PRGS icon
1142
Progress Software
PRGS
$1.72B
$4.71M 0.01%
132,640
+22,331
+20% +$745K
HOPE icon
1143
Hope Bancorp
HOPE
$1.83B
$4.7M 0.01%
395,881
+61,019
+18% +$873K
HPP
1144
Hudson Pacific Properties
HPP
$758M
$4.69M 0.01%
23,062
+345
+2% +$73.7K
G icon
1145
Genpact
G
$6.07B
$4.67M 0.01%
173,003
+25
+0% +$712
HZNP
1146
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.67M 0.01%
238,785
+75,099
+46% +$1.47M
DOC
1147
DELISTED
PHYSICIANS REALTY TRUST
DOC
$4.66M 0.01%
290,833
+79,301
+37% +$1.33M
BRX icon
1148
Brixmor Property Group
BRX
$9.57B
$4.65M 0.01%
316,260
+6,426
+2% +$101K
HMN icon
1149
Horace Mann Educators
HMN
$2.1B
$4.64M 0.01%
123,861
+20,999
+20% +$831K
RLJ icon
1150
RLJ Lodging Trust
RLJ
$1.89B
$4.62M 0.01%
281,521
+75,668
+37% +$1.47M

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.